AKTX – Akeso Inc.
Akari Therapeutics PlcAKTX
$15.00Name : Akari Therapeutics Plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $23,615,130.00
EPSttm :
Akari Therapeutics Plc
$15.00
2.88%$0.445
AKTX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
5.67
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
-2.88
EPS This/Next Y
0.55
Price
15.44
Target Price
33.5
Analyst Recom
2
Performance Q
45.91
Upside
-4,500.7%
Beta
1.33
Ticker: AKTX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | AKTX | 5.15 | N/A | N/A | 0 |
| 2026-05-12 | AKTX | 3.18 | N/A | N/A | 0 |
| 2026-05-13 | AKTX | 3.15 | N/A | N/A | 0 |
| 2026-05-14 | AKTX | 3.645 | N/A | N/A | 0 |
| 2026-05-15 | AKTX | 3.44 | N/A | N/A | 0 |
| 2026-05-18 | AKTX | 3.5 | N/A | N/A | 0 |
| 2026-05-19 | AKTX | 3.9 | N/A | N/A | 0 |
| 2026-05-20 | AKTX | 3.73 | N/A | N/A | 0 |
| 2026-05-21 | AKTX | 5.16 | N/A | N/A | 0 |
| 2026-05-22 | AKTX | 15.42 | N/A | N/A | 0 |
| 2026-05-26 | AKTX | 17.3 | N/A | N/A | 0 |
| 2026-05-27 | AKTX | 16 | N/A | N/A | 0 |
| 2026-05-28 | AKTX | 20.89 | N/A | N/A | 0 |
| 2026-05-29 | AKTX | 16.43 | N/A | N/A | 0 |
| 2026-06-02 | AKTX | 14.18 | N/A | N/A | 0 |
| 2026-06-03 | AKTX | 14.82 | N/A | N/A | 0 |
| 2026-06-04 | AKTX | 15.715 | N/A | N/A | 0 |
| 2026-06-05 | AKTX | 15.19 | N/A | N/A | 0 |
| 2026-06-08 | AKTX | 15.5226 | N/A | N/A | 0 |
| 2026-06-09 | AKTX | 15.37 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | AKTX | 5.02 | - | - | -12.00 |
| 2026-05-12 | AKTX | 3.06 | - | - | -12.00 |
| 2026-05-13 | AKTX | 3.12 | - | - | -12.00 |
| 2026-05-14 | AKTX | 3.58 | - | - | -12.00 |
| 2026-05-15 | AKTX | 3.70 | - | - | -12.00 |
| 2026-05-18 | AKTX | 3.65 | - | - | -12.00 |
| 2026-05-19 | AKTX | 3.35 | - | - | -12.00 |
| 2026-05-20 | AKTX | 3.73 | - | - | -12.00 |
| 2026-05-21 | AKTX | 4.79 | - | - | -12.00 |
| 2026-05-22 | AKTX | 17.92 | - | - | -12.00 |
| 2026-05-26 | AKTX | 17.60 | - | - | -2.88 |
| 2026-05-27 | AKTX | 16.22 | - | - | -2.88 |
| 2026-05-28 | AKTX | 23.66 | - | - | -2.88 |
| 2026-05-29 | AKTX | 16.00 | - | - | -2.88 |
| 2026-06-01 | AKTX | 13.88 | - | - | -2.88 |
| 2026-06-02 | AKTX | 14.33 | - | - | -2.88 |
| 2026-06-03 | AKTX | 15.00 | - | - | -2.88 |
| 2026-06-04 | AKTX | 15.70 | - | - | -2.88 |
| 2026-06-05 | AKTX | 15.06 | - | - | -2.88 |
| 2026-06-08 | AKTX | 15.53 | - | - | -2.88 |
| 2026-06-09 | AKTX | 15.44 | - | - | -2.88 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | AKTX | 0.00 | 336.95 | 0.03 |
| 2026-05-12 | AKTX | 0.00 | 336.95 | 0.04 |
| 2026-05-13 | AKTX | 0.00 | 336.95 | 0.04 |
| 2026-05-14 | AKTX | 0.00 | 336.95 | 0.04 |
| 2026-05-15 | AKTX | 0.00 | 336.95 | 0.04 |
| 2026-05-18 | AKTX | 0.00 | 0.07 | 0.04 |
| 2026-05-19 | AKTX | 0.00 | 0.07 | 0.04 |
| 2026-05-20 | AKTX | 0.00 | 0.07 | 0.04 |
| 2026-05-21 | AKTX | 0.00 | 0.07 | 0.04 |
| 2026-05-22 | AKTX | 0.00 | 0.07 | 1.42 |
| 2026-05-26 | AKTX | 0.00 | -39.16 | 1.42 |
| 2026-05-27 | AKTX | 0.00 | -39.16 | 1.42 |
| 2026-05-28 | AKTX | 0.00 | -39.16 | 5.67 |
| 2026-05-29 | AKTX | 0.00 | -39.16 | 5.67 |
| 2026-06-02 | AKTX | 0.00 | -39.16 | 5.67 |
| 2026-06-03 | AKTX | 0.00 | -39.16 | 5.67 |
| 2026-06-04 | AKTX | 0.00 | -39.16 | 5.67 |
| 2026-06-05 | AKTX | 0.00 | -39.16 | 5.67 |
| 2026-06-08 | AKTX | 0.00 | -47.98 | 5.67 |
| 2026-06-09 | AKTX | 0.00 | -47.98 | 5.67 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.69
Avg. EPS Est. Next Quarter
-0.75
Insider Transactions
Institutional Transactions
-47.98
Beta
1.33
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
9
Growth Score
17
Sentiment Score
49
Actual DrawDown %
99
Max Drawdown 5-Year %
-99.8
Target Price
33.5
P/E
Forward P/E
PEG
P/S
P/B
1.19
P/Free Cash Flow
EPS
-18.86
Average EPS Est. Cur. Y
-2.88
EPS Next Y. (Est.)
-2.34
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.02
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
-1
EPS 1 30Days Diff
2.71
EBIT Estimation
◆
AKTX
Healthcare
$15.00
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
58.9
Range 1M
47%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
72.1%
EPS NY
18.9%
52W%
25.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+123.3% upside
Upside
+123.3%
Quality
9
Akari Therapeutics PlcSector: Healthcare
Industry: Biotechnology
Employees: 5
Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Tampa, Florida.
AKTX
Latest News
—
Caricamento notizie per AKTX…
stock quote shares AKTX – Akeso Inc. Stock Price stock today
news today AKTX – Akeso Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AKTX – Akeso Inc. yahoo finance google finance
stock history AKTX – Akeso Inc. invest stock market
stock prices AKTX premarket after hours
ticker AKTX fair value insiders trading